Skip to content
Lower risk Medical device recall · FDA · Published August 7, 2017

Microvention Traxcess 7 Guidewire Recall: Hydrophilic Coating May Delaminate

Microvention recalls Traxcess 7 Mini Guidewires with hydrophilic coating that may delaminate. Affected units have specific lot numbers. Contact for remedy.

🇺🇸 FDA recall #Z-3103-2017Medical deviceMicrovention ›
Take action

Contact the company

Recalling firmMicrovention, Inc.1311 Valencia Ave · Tustin, CA 92780-6447
✎ GovInfoNow plain-language explainer

What happened, in plain English

Microvention is recalling Traxcess 7 Mini Guidewires with hydrophilic coating due to a potential risk of the coating delaminating. This could affect medical use and requires attention from healthcare providers. Read more at govinfonow.com/recall/73183-microvention-traxcess-7-guidewire-recall-hydrophilic-coating-may-delaminate.

Source Summary by GovInfoNow · govinfonow.com/recall/73183-microvention-traxcess-7-guidewire-recall-hydrophilic-coating-may-delaminate · Updated September 18, 2026 · FDA enforcement record: FDA #Z-3103-2017

Cite this page

“Microvention Traxcess 7 Guidewire Recall: Hydrophilic Coating May Delaminate.” GovInfoNow, updated September 18, 2026. https://govinfonow.com/recall/73183-microvention-traxcess-7-guidewire-recall-hydrophilic-coating-may-delaminate. Based on FDA recall #Z-3103-2017 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-3103-2017%22&limit=1).

Why it’s dangerous

The hydrophilic coating on the guidewire may separate from the wire during use. This could cause the wire to become unstable or malfunction in medical procedures.

Who’s affected

Healthcare professionals using the Traxcess 7 Mini Guidewires for medical procedures are most at risk. Patients using these devices are not directly affected.

How to tell if you have this one

Check for the model number GW0721006M on the packaging. Affected units have lot numbers 17030521, 17032821, or 17041831.

  • Brand
    Microvention
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Product Lot Number

    Look for lot numbers 17030521, 17032821, or 17041831 on the packaging.

Where it went and when

Where it was distributed

Distributed in 12 states.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: yesMNIllinois: not listedILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: not listedRIMassachusetts: yesMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: yesOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: not listedNEMissouri: yesMOKentucky: not listedKYWest Virginia: not listedWVVirginia: yesVAMaryland: not listedMDDelaware: not listedDEArizona: yesAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “Distribution was made to medical facilities located in AZ, CA, CO, MA, MI, MN, MO, NY, OH UT, VA, and WI. There was no foreign/military/government distribution.” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Arizona, California, Colorado, Massachusetts, Michigan, Minnesota, Missouri, New York, Ohio, Utah, Virginia, Wisconsin.

Recall timeline

FDA terminated this recall 15 months after the firm started it.

1. Firm started the recall: Aug 7, 201712. FDA classified it Class II: Sep 1, 201723. Published in FDA’s Enforcement Report: Sep 13, 201734. FDA terminated the recall: Oct 26, 2018420172018
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

The recall indicates a potential risk of coating delamination, but the product is generally safe unless the coating separates.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-3103-2017 (August 7, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-3103-2017 to see it in context.
  • Plain-language summary written by qwen3:4b on September 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA